Prospective pharmacoepidemiological evaluation of sirolimus as conversion immunosuppression after kidney transplantation in usual clinical practice:: Results of the ROAR™ trial

被引：0
|
作者：
Pescovitz, Mark [1 ]
Kasiske, Bertram [2 ]
Copley, Brian [3 ]
机构：
[1] Indiana Univ, Sch Med, Indianapolis, IN USA
[2] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA
[3] Wyeth Pharmaceut, Collegeville, PA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2008年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：515 / 515
页数：1
相关论文
共 50 条
  • [41] CNI- AND STEROID-FREE IMMUNOSUPPRESSION AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION: ONE-YEAR RESULTS OF A PROSPECTIVE AND RANDOMIZED STUDY
    Cantarovich, Diego
    Papuchon, Emmanuelle
    Guillot-Gueguen, Cecile
    Blancho, Gilles
    Dantal, Jacques
    Giral-Classe, Magali
    Branchereau, Julien
    Karam, Georges
    TRANSPLANT INTERNATIONAL, 2013, 26 : 172 - 172
  • [42] Conversion From Calcineurin Inhibitor to Either Mycophenolate Mofetil or Sirolimus Improves Renal Function in Liver Transplant Recipients With Chronic Kidney Disease: Results of a Prospective Randomized Trial
    Herlenius, G.
    Felldin, M.
    Norden, G.
    Olausson, M.
    Backman, L.
    Gustafsson, B.
    Friman, S.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (10) : 4441 - 4448
  • [43] Benefits of Early Everolimus-Based Quadruple Immunosuppression Early After Lung Transplantation - Results of 4EVERLUNG, a Prospective Randomized Multicenter Trial
    Gottlieb, J.
    Neurohr, C.
    Mueller-Quernheim, J.
    Wirtz, H.
    Sill, B.
    Wilkens, H.
    Besa, V.
    Knosalla, C.
    Junge, M.
    Capusan, C.
    Strueber, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S27 - S28
  • [44] Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation
    Mjornstedt, Lars
    Sorensen, Soren Schwartz
    von zur Muhlen, Bengt
    Jespersen, Bente
    Hansen, Jesper M.
    Bistrup, Claus
    Andersson, Helene
    Gustafsson, Bengt
    Solbu, Dag
    Holdaas, Hallvard
    TRANSPLANT INTERNATIONAL, 2015, 28 (01) : 42 - 51
  • [45] Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial
    Favi, E.
    Silvestrini, N.
    Spagnoletti, G.
    Castagneto, M.
    Citterio, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 147 - 147
  • [46] The european multicentre trial on kidney preservation: Results of a prospective randomised clinical study comparing post-transplant outcome after hypothermic machine perfusion versus simple cold storage in kidney transplantation
    Moers, Cyril
    Smits, Jacqueline M.
    Maathuis, Mark-Hugo
    Treckmann, Jurgen
    van Gelder, Frank
    Napieralski, Bogdan P.
    van Kasterop-Kutz, Margitta
    Malago, Massimo
    van der Heide, Jaap J. Homan
    Squifflet, Jean-Paul
    van Heurn, Ernst
    Kirste, Gunter R.
    Rahmel, Axel
    Leuvenink, Henri G. D.
    Paul, Andreas
    Pirenne, Jacques
    Ploeg, Rutger J.
    TRANSPLANT INTERNATIONAL, 2007, 20 : 34 - 34
  • [47] Long-term response to renal ischaemia in the human kidney after partial nephrectomy: results from a prospective clinical trial
    Kallingal, George J. S.
    Weinberg, Joel M.
    Reis, Isildinha M.
    Nehra, Avinash
    Venkatachalam, Manjeri A.
    Parekh, Dipen J.
    BJU INTERNATIONAL, 2016, 117 (05) : 766 - 774
  • [48] Impact of high risk molecular mutations after allogenic transplantation in myelofibrosis: long term results of a prospective GITMO clinical trial
    Salmoiraghi, S.
    Patriarca, F.
    Civini, A.
    Pavoni, C.
    Finazzi, M. C.
    Guglielmelli, P.
    Narni, F.
    Rumi, E.
    Russo, D.
    Messina, G.
    Bregante, S.
    Milone, G.
    Imovilli, A.
    Benedetto, B.
    Musso, M.
    Santarone, S.
    Pini, M.
    Corra-Dini, P.
    Spinelli, O.
    Bonifazi, F.
    Rambaldi, A.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 70 - 70
  • [49] 3 Year results of a prospective case control study using reduced dose calcineurin inhibitor (CNI) with sirolimus (SRL) compared to full dose CNI with mycophenylate mofetil (MMF) for immunosuppression in kidney transplantation.
    Formica, RN
    Kulkarni, SL
    Friedman, AL
    Bia, MJ
    Lorber, MI
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 241 - 241
  • [50] Time-restricted versus standard-duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON-96 trial
    Broers, Annoek E. C.
    Meijer, Ellen
    van der Holt, Bronno
    de Jong, Cornelis N.
    Nur, Erfan
    van Sluis, Geerte L.
    Choi, Goda
    van Gelder, Michel
    Maertens, Johan A.
    Kuball, Juergen
    Deeren, Dries
    Visser-Wisselaar, Heleen A.
    Meulendijks, Lamberdina A. H. M.
    Cornelissen, Jan J.
    HOVON Stem Cell Transplantation Working Grp
    HEMASPHERE, 2024, 8 (12):
12345